pharma news today glp-1 2025 marked a breakout year for weight-loss & drugs in India, with Mounjaro, Wegovy & Ozempic entering the market & Mounjaro emerging as the clear leader. As the semaglutide patent expiries GLP-1 Market Trends | Whitepaper

V.LiS.HigginbothamS

Injectable GLP-1s bypass the digestive system, so the dose can be smaller and absorption is more predictable

Search strategy and study selection We conducted a comprehensive systematic search across five electronic databases: PubMed, Embase, Web of Science, Scopus, and the Cochrane Library, as well as the Google Scholar search engine, from inception to September 30, 2025, to identify studies investigating the association between GLP-1 receptor agonists and AUD outcomes

The specialized nature of peptide APIs like tirzepatide demands particularly thorough provider qualification processes to ensure product quality and regulatory compliance